Navigation Links
Mylan Announces Appointment of John Montgomery as President, Asia Pacific
Date:10/2/2007

PITTSBURGH, Oct. 2 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of John Montgomery to the position of President, Asia Pacific following the completion of Mylan's acquisition of Merck's Generics Group today.

Mr. Montgomery has worked for over 30 years in the pharmaceuticals industry and has extensive experience in both patented and generics pharmaceutical products in the UK, U.S. and Asia Pacific regions. At Merck Generics, he served as Regional Director, Asia Pacific, and CEO of Alphapharm, Merck Generic's business in Australia and the country's leading pharmaceutical company as measured by prescriptions. Prior to joining Merck, he spent 18 years with Warner Lambert in the UK, U.S. and Australia in roles including Business Director, Europe; Vice President, Cardiovascular; Vice President of Portfolio Management for North America; and Regional President Australia/New Zealand. He served five years as Chairman of the Generic Medicines Industry Association (GMiA) in Australia.

Mylan Vice Chairman and CEO Robert J. Coury commented: "I have seen first hand that John is a truly skilled leader with the vision that makes him a perfect fit for Mylan. He brings an impressive track record and true depth of experience to our senior team. Asia Pacific is an important region with an attractive growth profile, particularly in Japan. Under John's leadership, his business ranks number one in both Australia and New Zealand, and also ranks as the leading multinational generics company in Japan. I am confident that we are extremely well-placed to leverage the many opportunities we see in the region from our position as a new global leader in the generics and specialty pharmaceutical industry."

Mr. Montgomery said: "I am very pleased to be joining the management team at Mylan and excited to be part of a company that is firmly focused on growing its generics and specialty pharmaceuticals businesses. There are great similarities between the culture and history of Mylan and Alphapharm, as well as the other Asia Pacific companies. This common culture, values and focus, combined with true global scale, will drive growth and reinforce our leading positions in the region, as well as create additional opportunities for our future success."

Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient (API) manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

Alphapharm is the largest pharmaceutical company in Australia as measured in prescriptions. The company develops, manufactures, markets and distributes generic and specialty prescription medicines. Merck Seiyaku Ltd. (Japan) was formed through the acquisitions of Hoei and Mohan, and is the fourth largest company in Japan's emerging generics market. The company is focused on specific therapeutic categories including antibiotics, oncology, skin and allergy, and metabolic diseases. Pacific Pharmaceuticals is the market leader in generics in New Zealand.

For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... , ... TLC Laser Eye Centers announced today that it has acquired Gordon ... be called “Gordon Schanzlin New Vision Institute, a TLC Laser Eye Center.” , ... ensure that patients continue to receive the highest quality of care. In addition, all ...
(Date:5/5/2016)... ... 05, 2016 , ... LELO has discovered many people are insecure ... out via email, social media and on the Volonté blog seeking advice about how ... masturbate ‘normal’ or ‘correct’?” , While some methods are more common than others, there ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... master charity program created to assist the people of their local community. The ... nonprofit organizations and community leaders. Their hope is to bring awareness to important ...
(Date:5/5/2016)... ... May 05, 2016 , ... Vitenas Cosmetic Surgery has ... Awards, presented by the American Institute of Architects and the Academy of Architecture for ... renowned Perkins+Will and Harrell Architects, opened to patients in October of 2014. ...
(Date:5/5/2016)... ... 2016 , ... Sun Health registered nurse Brittany Eads and ... Care Transitions program at the 9th Annual Orthopedic and Spine Summit held ... Post-Acute Environment Through Effective Transitions of Care.” , Major changes are taking place ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... Progra m m e ... Oxitec , s mosquito in Cayman Islands ... by 96 %   Oxitec and the Cayman ... wild Aedes aegypti, the dangerous mosquito that spreads dengue, Zika and ... Grand Cayman .  MRCU, a global leader in mosquito control, is ...
(Date:5/5/2016)... , May 5, 2016 /PRNewswire/ ... announced the addition of the  "Europe ... - 2016"  report to their offering.  ... ) , ,The latest research ... Highlights - 2016, provides comprehensive insights ...
(Date:5/4/2016)... May 4, 2016  Compass Diversified Holdings (NYSE: ... an owner of leading middle market businesses, announced today ... March 31, 2016. First Quarter 2016 Highlights ... Reinvestment ("CAD" or "Cash Flow") of $13.6 million for ... loss of $15.0 million for the first quarter of ...
Breaking Medicine Technology: